Kan AI diabetesprogressie voorspellen met behulp van retinale beeldgegevens ?

Diabetische retinopathie is een bekende complicatie van diabetes, maar veranderingen in het netvlies kunnen ook een bredere metabole disfunctie weerspiegelen. AI-modellen die retinascans analyseren, zouden vroege tekenen van diabetesprogressie kunnen detecteren voordat klinische symptomen optreden. Deze niet-invasieve aanpak zou proactief beheer van de ziekte mogelijk kunnen maken.

Background

Diabetic retinopathy is a well-known complication of diabetes, but retinal changes may also reflect broader metabolic dysfunction. AI models analyzing retinal scans could detect early signs of diabetes progression before clinical symptoms emerge. This non-invasive approach could enable proactive management of the disease.

Current AI systems can analyze retinal images to predict the onset and progression of diabetes with clinically useful accuracy. Models such as convolutional neural networks (CNNs) trained on large datasets like the UK Biobank and EyePACS can detect diabetic retinopathy and estimate related risks like future vision loss or cardiovascular events. These systems often achieve area-under-the-curve (AUC) metrics above 0.85 for predicting diabetic retinopathy progression over 1–2 years, though performance varies by population and imaging quality. Integration into clinical workflows is still limited by data standardization, regulatory approvals, and the need for longitudinal validation.

— Enriched May 12, 2026 · Source: Nature Medicine